HS
SWTX

HighVista Strategies’s SpringWorks Therapeutics SWTX Stock Holding History

HighVista Strategies’s Portfolio SWTX Stock Details SWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-68,758
Closed -$3.03M – 174
2025
Q1 		$3.03M Hold
68,758
– – 1.17% 12
2024
Q4 		$2.48M Buy
68,758
+32,906
+92% +$1.15M 0.92% 29
2024
Q3 		$1.15M Sell
35,852
-15,135
-30% -$565K 0.4% 97
2024
Q2 		$1.92M Hold
50,987
– – 0.7% 43
2024
Q1 		$2.51M Buy
+50,987
New +$2.36M 0.89% 34
2023
Q3 		– Sell
-11,688
Closed -$306K – 160
2023
Q2 		$306K Sell
11,688
-5,959
-34% -$157K 0.14% 132
2023
Q1 		$454K Sell
17,647
-17,156
-49% -$501K 0.37% 75
2022
Q4 		$905K Buy
34,803
+21,915
+170% +$540K 0.54% 50
2022
Q3 		$368K Sell
12,888
-6,192
-32% -$178K 0.21% 86
2022
Q2 		$470K Buy
19,080
+11,325
+146% +$414K 0.28% 77
2022
Q1 		$438K Sell
7,755
-10,115
-57% -$579K 0.28% 77
2021
Q4 		$1.11M Buy
17,870
+2,276
+15% +$151K 0.88% 40
2021
Q3 		$989K Buy
15,594
+4,963
+47% +$382K 0.65% 55
2021
Q2 		$876K Buy
10,631
+962
+10% +$73K 0.62% 30
2021
Q1 		$711K Sell
9,669
-2,743
-22% -$215K 0.53% 36
2020
Q4 		$900K Buy
12,412
+935
+8% +$60.2K 0.57% 35
2020
Q3 		$547K Buy
11,477
+828
+8% +$35.3K 0.4% 40
2020
Q2 		$447K Buy
+10,649
New +$379K 0.37% 34

Other funds holding SWTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BCM
Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
FTCM
First Trust Capital Management Chicago, Illinois $1.9B AUM 58.39% 1-Year Est. Return

HighVista Strategies's SWTX Position: Q2 2025 in Review

HighVista Strategies sold out of SpringWorks Therapeutics (SWTX) in Q2 2025, closing a stake of 68,758 shares — an estimated $3.03M sold.

HighVista Strategies first reported a position in SWTX in Q2 2020 and held it in 18 quarters. The position peaked at $3.03M in Q1 2025. 222 funds tracked by Wall St. Rank hold SWTX as of Q2 2025.

  • HighVista Strategies reported no remaining SpringWorks Therapeutics position as of Q2 2025 after selling out during the quarter.
  • HighVista Strategies sold 68,758 SpringWorks Therapeutics shares in Q2 2025, an estimated $3.03M.
  • HighVista Strategies first reported a position in SpringWorks Therapeutics in Q2 2020 and held it in 18 quarters.
  • HighVista Strategies's SpringWorks Therapeutics position peaked at $3.03M in Q1 2025.
  • 222 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q2 2025.

Based on HighVista Strategies's 13F filing for Q2 2025, filed 14 Aug 2025.